Bansk Beauty’s Reuben Carranza on building a distinct brand that lasts

Nov 6, 2025

Reuben Carranza, Executive Chairman of Bansk Beauty, shares his extensive experience in the beauty industry, including his time at P&G and Kate Somerville. He discusses Bansk's strategy in acquiring Byoma, highlighting its unique story and approach to simplifying skincare. Reuben also delves into the importance of aligning marketing strategies with brand purpose, how consumer expectations are reshaping the market, and the exciting trends in wellness and scalp care. Plus, he offers invaluable career advice for those aspiring to lead in the brand world.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Late-Stage Operator Investment Focus

Bonks targets late-stage, profitable brands at least a decade old with clear scaling potential.
Reuben focuses on operator-led growth rather than pure finance plays to extend brand trajectories.

INSIGHT

Why Byoma Fit Bansk's Portfolio

Bansk acquired Byoma for its simple, clinically grounded story and rapid growth trajectory.
The brand pairs barrier-first Korean-inspired formulas with accessible price and clinical credibility.

INSIGHT

Longevity And Scalp Care Are Rising

Longevity and wellness are converging with beauty and driving major industry focus.
Scalp health is emerging as a parallel growth category within haircare innovation.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

Reuben Carranza knows a good brand when he sees it.

Bansk Beauty, where he serves as executive chairman, made headlines in September after acquiring the buzzy, clinical skin-care brand Byoma. It’s part of the late-stage private investment firm’s growing beauty roster, which includes Amika, Eva NYC and Ethique.

“No. 1, they're on a tear, right? They're growing rapidly. But I think what we loved about them was the story,” he told Glossy on stage at this week’s annual Glossy Beauty and Wellness Summit about its Byoma acquisition. “It's the story: they've de-complicated complicated skin-care routines.”

Carranza kicked off the Summit with a special live podcast recording, where he shared insights into the firm’s investment philosophy and growth plans for its brands. He also shared career advice from his stacked CV, which includes more than two decades at P&G and leadership roles at R+Co Hair, Kate Somerville skin care, and more.

This special session is ahead, but first, hosts Lexy Lebsack and Emily Jensen share highlights from the Summit and dig into the news of the week.

First up, the hosts break down the latest from Tylenol- and Neutrogena-owner Kenvue. Kimberly-Clark Corp. will acquire Kenvue Inc. in a deal valued at $48.7 billion. Kimberly-Clark's portfolio includes consumer brands like Huggies, Kleenex and Cottonelle.

Next up, a look at Skims’s buzzy new hire. Diarrha N’Diaye was named evp, beauty and fragrance of Kim Kardashian’s upcoming Skims Beauty. N’Diaye has worked in marketing and branding for the likes of Glossier and L’Oréal, and was most recently the founder of Ami Colé, which shuttered in July. She will lead product development, innovation and brand strategy for Skims's upcoming beauty launch.

Finally, an analysis of a hefty investment in Blueprint, the supplement company from American entrepreneur and biohacker Bryan Johnson. The company has taken on $60 million in funding from investors like Kim Kardashian, Ari Emanuel, Cameron and Tyler Winklevoss, and many more big names. Johnson is best known for documenting his quest to age in reverse on YouTube and through the Netflix film “Don’t Die.” Blueprint currently offers a variety of products DTC, including drink mixes, supplements and skin care.